4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-001986
EVP & Chief Financial Officer sold 6,061 shares at an average $26.37 ($159,811)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly James Patrick EVP & Chief Financial Officer | 2019-01-02 | Sale | −3,313 | $26.31 | $87,165 | 196,221 | D: show line 1 in the form |
| Kelly James Patrick EVP & Chief Financial Officer | 2019-01-02 | Sale | −1,129 | $26.94 | $30,414 | 195,092 | D: show line 2 in the form |
| Kelly James Patrick EVP & Chief Financial Officer | 2019-01-03 | Sale | −1,619 | $26.09 | $42,232 | 193,473 | D: show line 3 in the form |
| Open-market sales · 6,061 sh · avg $26.37 · $159,811 | |||||||
Loading xslF345X03/doc4.xml…